title: Long-term survival after liver transplantation for alcoholic liver disease.
abstract: Currently, alcoholic cirrhosis is the second leading indication for liver transplantation in the United States and Europe. The quality of life and survival after a liver transplantation (LT) in patients with alcoholic liver disease (ALD) are similar to those in patients with other cirrhosis etiologies. The alcoholic relapse rate after a LT varies from 10%-50%, and these relapse patients are the ones who present a reduced long-term survival, mainly due to cardiovascular diseases and the onset of de novo neoplasms, including lung and upper aerodigestive tract. Nearly 40% of ALD recipients resume smoking and resume it early post-LT. Therefore, our pre-and post-LT follow-up efforts regarding ALD should be focused not only on alcoholic relapse but also on treating and avoiding other modifiable risk factors such as tobacco. The psychiatric and psychosocial pre-LT evaluation and the post-LT follow-up with physicians, psychiatrists and addiction specialists are important for reversing these problems because these professionals help to identify patients at risk for relapse as well as those patients who have relapsed, thus enabling responsive actions.
authors.affiliation: Paula Iruzubieta, Javier Crespo, Emilio Fábrega, Gastroenterology and Hepatology Unit, Marqués de Valdecilla University Hospital, Instituto de Formación e Investigación Marqués de Valdecilla (IFIMAV), 39008 Santander, Cantabria, Spain.
authors.forename: Paula
authors.initials: P
authors.lastname: Iruzubieta
authors.affiliation: Paula Iruzubieta, Javier Crespo, Emilio Fábrega, Gastroenterology and Hepatology Unit, Marqués de Valdecilla University Hospital, Instituto de Formación e Investigación Marqués de Valdecilla (IFIMAV), 39008 Santander, Cantabria, Spain.
authors.forename: Javier
authors.initials: J
authors.lastname: Crespo
authors.affiliation: Paula Iruzubieta, Javier Crespo, Emilio Fábrega, Gastroenterology and Hepatology Unit, Marqués de Valdecilla University Hospital, Instituto de Formación e Investigación Marqués de Valdecilla (IFIMAV), 39008 Santander, Cantabria, Spain.
authors.forename: Emilio
authors.initials: E
authors.lastname: Fábrega
mesh_terms: D064829:Alcohol Abstinence; D000428:Alcohol Drinking / Q000009:adverse effects / Q000517:prevention & control; D015438:Health Behavior; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008019:Life Style; D008108:Liver Diseases, Alcoholic / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000523:psychology / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality; D011183:Postoperative Complications / Q000517:prevention & control; D011788:Quality of Life; D012008:Recurrence; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation; D000074606:Smoking Prevention; D013997:Time Factors; D016896:Treatment Outcome
keywords: Alcohol recidivism; Alcohol relapse prevention; Alcoholic liver disease; Liver transplantation; Long term survival